Peak Pharmaceuticals (OTCMKTS:PKPH) Shares Down 0.6% – Here’s Why

Peak Pharmaceuticals, Inc. (OTCMKTS:PKPHGet Free Report)’s share price was down 0.6% on Monday . The stock traded as low as $0.7270 and last traded at $0.90. Approximately 253 shares were traded during mid-day trading, a decline of 97% from the average daily volume of 9,053 shares. The stock had previously closed at $0.9055.

Peak Pharmaceuticals Stock Down 0.6%

The firm’s 50 day moving average is $1.56 and its two-hundred day moving average is $1.76.

About Peak Pharmaceuticals

(Get Free Report)

Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.

Featured Articles

Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.